MM

Michelle Miller

Biotron Limited | Managing Director
Dr Miller has worked for over 25 years in the bioscience industry, with experience in commercial drug development. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes several years at Johnson & Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund. Dr Miller was appointed as Managing Director on 21 June 2002.

Company and Role

Company
Title
Tenure
Since
BIT
Biotron Limited
  • Managing Director
22yrs, 1mthJun 2002

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BIT
Biotron Limited
26/11/231,987,5001,800,000315,625N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BIT
Biotron Limited
25/11/22
Issued
331,250$0.057$18,937Rights issue
BIT
Biotron Limited
25/11/22
Issued
315,625$0.028$8,837Rights issue
BIT
Biotron Limited
25/11/22
Issued
300,000$0.030$9,000Rights issue
BIT
Biotron Limited
23/12/19
Issued
7,000,000$0.055$385,000Issue of options
BIT
Biotron Limited
05/12/19
Transfer
1,500,000$0.060$90,000Off-market transfer